Somnogenic activity of immune response modifiers
1Department of Physiology and Biophysics, College of Medicine, University of Tennessee Memphis 38163.
Abstract:
Sleepiness is a presenting symptom in nearly all infectious diseases. James Krueger describes how microbial products, such as muramyl peptides, lipid A and double-stranded RNA, as well as endogenous products elicited by these substances, such as interleukin 1, modulate sleep. The altered sleep during infection seems to result from an exaggerated activation of physiological sleep mechanisms, since normal sleep is controlled by a wide range of substances including many of these immune response modifiers.
Insights
Infectious diseases often cause sleepiness by activating normal sleep pathways. Microbial and immune substances like interleukin-1 exaggerate these mechanisms, altering sleep patterns during illness.
Area of Science:
- Neuroscience
- Immunology
- Sleep Medicine
Background:
- Sleepiness is a common symptom across various infectious diseases.
- Microbial products and immune responses are implicated in altering sleep during infection.
Purpose of the Study:
- To explore the mechanisms by which microbial and endogenous substances modulate sleep during infection.
- To understand how physiological sleep mechanisms are affected during illness.
Main Methods:
- Review of existing literature on sleep modulation by immune response modifiers.
- Analysis of the role of specific microbial products (muramyl peptides, lipid A, double-stranded RNA) and endogenous substances (interleukin-1) in sleep regulation.
Main Results:
- Microbial products and elicited endogenous substances, such as interleukin-1, significantly influence sleep.
- Altered sleep during infection appears to stem from an overactivation of the body's natural sleep mechanisms.
Conclusions:
- Normal sleep is regulated by a complex interplay of substances, including immune response modifiers.
- The exaggerated activation of these physiological sleep mechanisms contributes to altered sleep during infectious diseases.
More Related Videos
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Cells of the Adaptive Immune Response
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
